PROTAC CDK2/9 Degrader-1 Chemical Properties

Density 

1.534±0.06 g/cm3(Predicted)

storage temp. 

Store at -20°C

solubility 

DMSO : 130 mg/mL (159.34 mM; Need ultrasonic)

form 

Solid

pka

10.74±0.40(Predicted)

color 

White to yellow

PROTAC CDK2/9 Degrader-1 Usage And Synthesis

Biological Activity

PROTAC CDK2/9 Degrader-1 (Compound F3) is a potent dual degrader for CDK2 (DC50=62 nM) and CDK9 (DC50=33 nM). PROTAC CDK2/9 Degrader-1 suppresses prostate cancer PC-3 cell proliferation (IC50=0.12 μM) by effectively blocking the cell cycle in S and G2/M phases. PROTAC CDK2/9 Degrader-1 is a PROTAC by tethering CDK inhibitor with CRBN ligand[1]. PROTAC CDK2/9 Degrader-1 (0.25-3 μM; 48 hours) induces cell cycle blockage at the G2/M phase[1].PROTAC CDK2/9 Degrader-1 (500 nM; 2-24 hours) down-regulates the Mcl-1 protein level in PC-3 cells[1].PROTAC CDK2/9 Degrader-1 effectively degrades CDK2/9 in cell lines MCF-7, HCT-116 and 22Rv1, which all have high CDK2/9 expression[1].PROTAC CDK2/9 Degrader-1 inhibits both CDK2 and CDK9, with IC50 as 7.42 nM and 14.50 nM, respectively[1].

References

[1]. Zhou F, et al. Development of selective mono or dual PROTAC degrader probe of CDK isoforms. Eur J Med Chem. 2019 Dec 6;187:111952.

PROTAC CDK2/9 Degrader-1(2408641-24-5)Related Product Information

• PROTAC FLT-3 degrader 1
• PROTAC CRBN Degrader-1
• PROTAC IRAK4 degrader-1
• PROTAC BRD4 Degrader-2
• PROTAC Bcl2 degrader-1
• PROTAC BET degrader-2
• PROTAC 11
• PROTAC BRD4 Degrader-1
• PROTAC ER Degrader-3
• CDK9-PROTAC
• PROTAC ERRα Degrader-2
• PROTAC FKBP Degrader-3
• PROTAC ER Degrader-4
• PROTAC BRD4 Degrader-5
• PROTAC B-Raf degrader 1
• PROTAC BRD9 Degrader-1
• PROTAC ERRα Degrader-1
• PROTAC K-Ras Degrader-1